Get started
Author

Gehad M. Subaiea

Observed names: G. M. Subaiea, G. Subaiea, Gehad M Subaiea, Gehad M. Subaie, Gehad Mohammed Subaiea, Gehad Muhammed Subaiea, Gehad Subaie, Gehad Subaiea, GehadM Subaiea, M Subaiea, Subaiea Gm, Subaiea, Gehad Mohammed
Institution: University of Ha'il
ORCID: 0000-0001-9212-7786
Observed ORCID: 0000-0001-9212-7786
OpenAlex ID: A5071917754
Healthcare professionals’ knowledge, attitude and acceptance of influenza vaccination in Saudi Arabia: a multicenter cross-sectional study
2019 · Thamir M. Alshammari, Kazeem B. Yusuff, et al. · BMC Health Services Research · 99
PDF
Infantile exposure to lead and late‐age cognitive decline: Relevance to AD
2013 · Syed Waseem Bihaqi, Azadeh Bahmani, et al. · Alzheimer s & Dementia · 96
Parental perceptions, attitudes and acceptance of childhood immunization in Saudi Arabia: A cross sectional study
2017 · Thamir M. Alshammari, Gehad M. Subaiea, et al. · Vaccine · 61
Energy drinks and population health: consumption pattern and adverse effects among Saudi population
2019 · Gehad M. Subaiea, Ali F. Altebainawi, et al. · BMC Public Health · 53
PDF
Pomegranate Extract Modulates Processing of Amyloid-β Precursor Proteinin an Aged Alzheimer’s Disease Animal Model
2014 · A Ahmed, M Subaiea, et al. · Current Alzheimer Research · 47
Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers
2014 · Lina Adwan, Gehad M. Subaiea, et al. · Neuropharmacology · 43
Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice
2013 · Gehad M. Subaiea, Lina I. Adwan, et al. · Neurobiology of Aging · 43
Developmental exposure to lead (Pb) alters the expression of the human tau gene and its products in a transgenic animal model
2016 · M. Dash, A. Eid, et al. · NeuroToxicology · 34
Current Status of Brain Tumor in the Kingdom of Saudi Arabia and Application of Nanobiotechnology for Its Treatment: A Comprehensive Review
2021 · Afrasim Moin, Syed Mohd Danish Rizvi, et al. · Life · 32
PDF
Knowledge, awareness, attitude, and practice of health-care professionals toward hepatitis B disease and vaccination in Saudi Arabia
2019 · Thamir M. Alshammari, Mohamad Aljofan, et al. · Human Vaccines & Immunotherapeutics · 32
PDF
Tolfenamic Acid Interrupts the De Novo Synthesis of the β-Amyloid Precursor Protein and Lowers Amyloid Beta Via a Transcriptional Pathway
2011 · L. I. Adwan, R. Basha, et al. · Current Alzheimer Research · 32
Tolfenamic acid reduces tau and CDK 5 levels: implications for dementia and tauopathies
2014 · Lina Adwan, Gehad M. Subaiea, et al. · Journal of Neurochemistry · 31
Influence of Early Life Lead (Pb) Exposure on α-Synuclein, GSK-3β and Caspase-3 Mediated Tauopathy: Implications on Alzheimer’s Disease
2018 · Syed Waseem Bihaqi, Bothaina Alansi, et al. · Current Alzheimer Research · 30
Fabrication and Characterization of Paclitaxel and Resveratrol Loaded Soluplus Polymeric Nanoparticles for Improved BBB Penetration for Glioma Management
2021 · Talib Hussain, Sathishbabu Paranthaman, et al. · Polymers · 29
PDF
The Ability of Tolfenamic Acid to Penetrate the Brain: A Model for Testing the Brain Disposition of Candidate Alzheimers Drugs Using Multiple Platforms
2011 · Gehad M. Subaiea, Bothaina H. Alansi, et al. · Current Alzheimer Research · 27
Ganetespib with Methotrexate Acts Synergistically to Impede NF-κB/p65 Signaling in Human Lung Cancer A549 Cells
2023 · Gehad Subaiea, Syed Mohd Danish Rizvi, et al. · Pharmaceuticals · 22
PDF
Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy
2018 · Joanna K. Chang, Allison Leso, et al. · Current Alzheimer Research · 21
Altered microRNA, mRNA, and Protein Expression of Neurodegeneration-Related Biomarkers and Their Transcriptional and Epigenetic Modifiers in a Human Tau Transgenic Mouse Model in Response to Developmental Lead Exposure
2018 · Anwar M. Masoud, Syed W. Bihaqi, et al. · Journal of Alzheimer s Disease · 20
Hepatoprotective evaluation of Trapa natans against drug-induced hepatotoxicity of antitubercular agents in rats
2018 · Talib Hussain, GehadM Subaiea, et al. · Pharmacognosy Magazine · 17
Reduction of Amyloid-β Deposition and Attenuation of Memory Deficits by Tolfenamic Acid
2014 · Gehad M. Subaiea, Aseef H. Ahmed, et al. · Journal of Alzheimer s Disease · 17
Non-coding RNAs (ncRNAs) and multidrug resistance in glioblastoma: Therapeutic challenges and opportunities
2023 · Gehad Mohammed Subaiea, Rahamat Unissa Syed, et al. · Pathology - Research and Practice · 13
Tailored Intranasal Albumin Caged Selegiline-α Synuclein siRNA Liposome with Improved Efficiency in Parkinson’s Model
2025 · Ahmed A. Katamesh, Hend Mohamed Abdel-Bar, et al. · Pharmaceutics · 10
PDF
Molecular docking and dynamic simulation study to explore quercetin as a multi-potent candidate against gliomas
2022 · Syed Mohd Danish Rizvi, Talib Hussain, et al. · Tropical Journal of Pharmaceutical Research · 10
PDF
Therapeutic Targeting of Amyloid Precursor Protein and its Processing Enzymes for Breast Cancer Treatment
2017 · Syed Mohd. Danish Rizvi, Talib Hussain, et al. · Current Protein and Peptide Science · 10
Vesicular drug delivery systems: A breakthrough in wound healing therapies
2025 · Amr Selim Abu Lila, Mahmoud Mostafa, et al. · Colloids and Surfaces B Biointerfaces · 7
Works count: 47
Citation count: 880
H-index: 18
I10-index: 24
Year
Topic
Type